Apply for funding
Cure Parkinson’s funds both pre-clinical and clinical research projects that have the potential to cure Parkinson’s.
By “cure”, we mean “disease-modifying” therapies that potentially slow, stop or reverse the disease progression of Parkinson’s. In addition, we prioritise research which has the potential to translate into the clinic within five years.
Our Director of Research, Dr Simon Stott explains this in more detail, in the video below.
Our funding programmes
Quarterly Research Grant Funding Programme
This programme primarily funds pre-clinical and clinical research focused on disease modification to slow, stop, or reverse Parkinson’s. For pre-clinical research, projects that could lead to clinical trials in Parkinson’s within 5 years are prioritised. We only fund clinical research in people with Parkinson’s.
iLCT Pipeline Research Acceleration Programme
This programme funds research that has been outlined by our international Linked Clinical Trials (iLCT) committee to be necessary before a therapy can move into clinical trials for Parkinson’s. Depending on the therapy, this may be pre-clinical, epidemiological, dose finding or target engagement research.
